P0788 : Estimating the cost-effectiveness of daclatasvir plus sofosbuvir in treatment-naïve, treatment-experienced and interferon-ineligible/intolerant patients with advanced chronic hepatitis C genotype 1 infection

Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options

Journal of Viral Hepatitis ◽

10.1111/jvh.12278 ◽

2014 ◽

Vol 22 (2) ◽

pp. 175-183 ◽

Cited By ~ 14

Author(s):

P. A. Cortesi ◽

A. Ciaccio ◽

M. Rota ◽

J. K. Lim ◽

S. De Salvia ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Treatment Options ◽

Genotype 1 ◽

Effectiveness Analysis ◽

1102 THE COST-EFFECTIVENESS OF TELAPREVIR (TVR) IN COMBINATION WITH PEGYLATED INTERFERON-ALFA AND RIBAVIRIN (PR) FOR THE TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS

Journal of Hepatology ◽

10.1016/s0168-8278(12)61114-3 ◽

2012 ◽

Vol 56 ◽

pp. S434 ◽

Cited By ~ 3

Author(s):

S. Curtis ◽

S. Cure ◽

S. Gavart ◽

L. Dearden ◽

J. Fleischmann ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 1 ◽

Pegylated Interferon Alfa ◽

The Cost ◽

Chronic Hepatitis C Patients

PIN62 Cost-Effectiveness of Triple Therapy With Telaprevir for the Treatment of Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients in Germany

Value in Health ◽

10.1016/j.jval.2012.08.1129 ◽

2012 ◽

Vol 15 (7) ◽

pp. A396

Author(s):

J.T. Stahmeyer ◽

S. Schauer ◽

D. Wirth ◽

J. Fleischmann ◽

S. Lee ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Treatment Naïve ◽

Chronic Hepatitis C Patients

The Cost-Effectiveness of Treatments in Non-Cirrhotic Saudi Arabian Patients with Genotype 1 and Genotype 4 Chronic Hepatitis C

Acta Scientific Pharmaceutical Sciences ◽

10.31080/asps.2020.04.0579 ◽

2020 ◽

Vol 4 (9) ◽

pp. 03-14

Author(s):

Mohammad Alowairdhi ◽

Varun Vaidya ◽

Eric Sahloff ◽

Cindy Puffer

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Saudi Arabian ◽

Genotype 1 ◽

Genotype 4 ◽

The Cost

Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naïve chronic hepatitis C genotype 1 patients in Japan

Journal of Medical Economics ◽

10.3111/13696998.2015.1029492 ◽

2015 ◽

Vol 18 (7) ◽

pp. 502-511 ◽

Cited By ~ 8

Author(s):

Hiroyo Kuwabara ◽

Kirsten Westerhout ◽

Maarten Treur ◽

Karin Cerri ◽

Joerg Mahlich ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Effectiveness Analysis ◽

Treatment Naïve ◽

Peginterferon And Ribavirin

P1215 MANAGEMENT OF CHRONIC HEPATITIS C (CHC) GENOTYPE 1 TREATMENT-NAIVE PATIENTS IN AN ERA OF RISING OPPORTUNITIES AND COSTS – A COST-EFFECTIVENESS ANALYSIS OF TREATMENT OPTIONS

Journal of Hepatology ◽

10.1016/s0168-8278(14)61375-1 ◽

2014 ◽

Vol 60 (1) ◽

pp. S493 ◽

Cited By ~ 1

Author(s):

P.A. Cortesi ◽

A. Ciaccio ◽

M. Rota ◽

S. De Salvia ◽

M. Vinci ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Treatment Options ◽

Genotype 1 ◽

Effectiveness Analysis ◽

COST-EFFECTIVENESS OF ANTIVIRAL THERAPY IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C (GENOTYPE 1) WITH VARIOUS SEVERITY OF FIBROSIS STAGE

Journal Infectology ◽

10.22625/2072-6732-2017-9-4-93-101 ◽

2017 ◽

Vol 9 (4) ◽

pp. 93-101 ◽

Cited By ~ 2

Author(s):

A. V. Rudakova ◽

D. A. Gusev ◽

A. N. Uskov ◽

I. V. Shestakova ◽

Yu. V. Lobzin

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Antiviral Therapy ◽

Chronic Hepatitis C ◽

Fibrosis Stage ◽

Genotype 1 ◽

Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis

Digestive and Liver Disease ◽

10.1016/j.dld.2014.01.028 ◽

2014 ◽

Vol 46 ◽

pp. e11

Author(s):

P.A. Cortesi ◽

A. Ciaccio ◽

M. Rota ◽

S. De Salvia ◽

S. Okolicsanyi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Effectiveness Analysis ◽

The Cost-Effectiveness of Treatments in Non-Cirrhotic Saudi Arabian Patients with Genotype 1 and Genotype 4 Chronic Hepatitis C

Value in Health ◽

10.1016/j.jval.2018.04.570 ◽

2018 ◽

Vol 21 ◽

pp. S84

Author(s):

M Alowairdhi

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Saudi Arabian ◽

Genotype 1 ◽

Genotype 4 ◽

The Cost

Cost-Effectiveness of Telaprevir Plus Peginterferon/Ribavirin (TVR+PR) Versus Peginterferon/Ribavirin (PR) in Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients with F2 Fibrosis in Brazil

Value in Health ◽

10.1016/j.jval.2013.08.185 ◽

2013 ◽

Vol 16 (7) ◽

pp. A354

Author(s):

A.D. Morais ◽

M.L. Pereira

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Treatment Naïve ◽

Chronic Hepatitis C Patients